Using a multi-strain probiotic formulation, researchers conducted a double-blind, randomized, placebo-controlled trial aimed at improving psychiatric and cognitive symptoms, intestinal permeability, ...

Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...

A woman "self-medicating" with cocaine "to treat her schizophrenia" carried out a number of attacks on nurses at Leicester ...

Just after 11 a.m. on Wednesday, a 17-year-old male student at Antioch High School opened fire inside the school's cafeteria, ...

Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights ..

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...

Among people with schizophrenia, men's symptoms tend to begin in their late teens to early 20s, while women's symptoms typically emerge in their 20s and early 30s. Psychosis also tends to develop ...

Summary: A study revealed that both men and women with greater upper body strength report more lifetime sexual partners, challenging the sexual selection hypothesis, which emphasizes male physical ...

However, research published today in JAMA Network Open indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia. 1 A ...

The Food and Drug Administration approved the first new drug in over 30 years to treat schizophrenia in adults. The new drug Cobenfy, formerly known as KarXT, is manufactured by Bristol Myers ...